Antidepressant drugs in cancer patients: the case of escitalopram.
Tsali
Lamprini
L
Bristianou
Magdalini
M
Valachis
Antonis
A
Mauri
Davide
D
Barotsis
Nikolaos
N
Bellou
Evangelia
E
D000368:Aged; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D001932:Brain Neoplasms / Q000150:complications / Q000628:therapy; D015283:Citalopram / Q000009:adverse effects*; D005260:Female; D005909:Glioblastoma / Q000150:complications / Q000628:therapy; D006801:Humans; D007010:Hyponatremia / Q000139:chemically induced*; D007177:Inappropriate ADH Syndrome / Q000139:chemically induced*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*
D018687:Antidepressive Agents, Second-Generation; D015283:Citalopram; D017367:Selective Serotonin Reuptake Inhibitors